Towards a sequential microbiome therapy for HPV-associated cervicovaginal dysbiosis
Open Access
- 29 October 2026
- journal article
- perspective
- Published by Springer Nature in Communications Biology
- Vol. 9 (1) , 1422
Abstract
Persistent high-risk human papillomavirus (hrHPV) infections are the principal cause of cervical cancer, and are increasingly associated with ecological instability of the cervicovaginal microbiome. Multiomics studies indicate that hrHPV persistence is linked to reduced Lactobacillus dominance, increased anaerobic taxa, and metabolic alterations that may compromise epithelial integrity and antiviral immunity. In this Perspective article, we introduce a sequential microbiome therapy (SMT) framework designed to restore cervicovaginal ecological balance and support viral clearance. SMT is a two-phase, strain-resolved strategy. The first phase targets dysbiotic communities using antimicrobials, biofilm-disrupting or microbiota-modulating approaches to create a window for ecological reset. The second phase introduces health-associated Lactobacillus species selected for their acidification capacity, competitive fitness, and ability to stabilize the mucosal environment. We outline the ecological principles underpinning SMT and discuss its development as a potentially scalable microbiome-directed strategy for restoring cervicovaginal health and managing hrHPV-associated disease within existing cervical cancer prevention frameworks.Keywords
This publication has 109 references indexed in Scilit:
- Male partner treatment and the potential sexual transmission of bacterial vaginosis: considerations for patient counseling and clinical application in the United StatesAmerican Journal of Obstetrics and Gynecology, 2025
- Exploring the Clinical Signatures of Cervical Dysplasia Patients and Their Association With Vaginal MicrobiotaCancer Medicine, 2024
- The association between lifestyle factors and the composition of the vaginal microbiota: a reviewEuropean Journal of Clinical Microbiology & Infectious Diseases, 2024
- Efficacy of Dequalinium Chloride vs Metronidazole for the Treatment of Bacterial VaginosisJAMA Network Open, 2024
- The Vaginal Microbiota, Human Papillomavirus Infection, and Cervical Carcinogenesis: A Systematic Review in the Latina PopulationJournal of Epidemiology and Global Health, 2024
- Inhibitory effect of Lactobacillus gasseri CCFM1201 on Gardnerella vaginalis in mice with bacterial vaginosisArchives of Microbiology, 2022
- Recurrent bacterial vaginosis following metronidazole treatment is associated with microbiota richness at diagnosisAmerican Journal of Obstetrics and Gynecology, 2021
- The use of 3 selected lactobacillary strains in vaginal probiotic gel for the treatment of acute Candida vaginitis: a proof-of-concept studyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2020
- Impact of oral metronidazole treatment on the vaginal microbiota and correlates of treatment failureAmerican Journal of Obstetrics and Gynecology, 2020
- Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysisAmerican Journal of Obstetrics and Gynecology, 2019